KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Current Assets (2016 - 2026)

Medtronic's Current Assets history spans 13 years, with the latest figure at $24.1 billion for Q1 2026.

  • On a quarterly basis, Current Assets rose 6.92% to $24.1 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $24.1 billion, a 6.92% increase, with the full-year FY2025 number at $23.8 billion, up 8.57% from a year prior.
  • Current Assets hit $24.1 billion in Q1 2026 for Medtronic, roughly flat from $24.0 billion in the prior quarter.
  • Over the last five years, Current Assets for MDT hit a ceiling of $25.4 billion in Q4 2022 and a floor of $21.7 billion in Q2 2023.
  • Historically, Current Assets has averaged $23.0 billion across 5 years, with a median of $22.5 billion in 2024.
  • Biggest five-year swings in Current Assets: grew 11.73% in 2022 and later dropped 13.06% in 2023.
  • Tracing MDT's Current Assets over 5 years: stood at $25.4 billion in 2022, then dropped by 13.06% to $22.1 billion in 2023, then grew by 1.62% to $22.4 billion in 2024, then grew by 6.94% to $24.0 billion in 2025, then rose by 0.31% to $24.1 billion in 2026.
  • Business Quant data shows Current Assets for MDT at $24.1 billion in Q1 2026, $24.0 billion in Q4 2025, and $23.2 billion in Q3 2025.